fbpx
January 20, 2022

Safety trial finds risk of blood clots in the lungs and death with higher dose of tofacitinib (Xeljanz, Xeljanz XR) in rheumatoid arthritis patients; FDA to investigate

Listen Welcome to the FDA Drug Safety Podcast for health care professionals from the Division of Drug Information. This is Lesley Navin, Advanced Practice Nurse. On […]
January 20, 2022

Safety clinical trial shows possible increased risk of cancer with weight-loss medicine Belviq, Belviq XR (lorcaserin)

Listen Welcome to the FDA Drug Safety Podcast for health care professionals from the Division of Drug Information. On January 14, 2020, FDA alerted the public […]
January 20, 2022

FDA warns that symptoms of a serious condition affecting the blood cells are not being recognized with the leukemia medicine Idhifa (enasidenib)

Listen Welcome to the FDA Drug Safety Podcast for health care professionals from the Division of Drug Information. This is Lesley Navin Advanced Practice Nurse. On […]
January 19, 2022

FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR)

Listen Welcome to the FDA Drug Safety Podcast for health care professionals from the Division of Drug Information. On December 19, 2019 FDA is warning that […]
January 19, 2022

FDA Drug Safety Podcast: FDA warns about serious bleeding risk with over-the-counter antacid products containing aspirin

Listen Welcome to FDA Drug Safety Podcasts for health care professionals. This is Lesley Navin, Advanced Practice Nurse from the Division of Drug Information. On June […]
January 19, 2022

FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi in some patients with advanced liver disease

Listen Welcome to the FDA Drug Safety Podcast for health care professionals from the Division of Drug Information. This is Lesley Navin Advanced Practice Nurse. On […]
January 19, 2022

FDA warns about rare but severe lung inflammation with Ibrance, Kisqali, and Verzenio for breast cancer

Listen > Welcome to the FDA Drug Safety Podcast for health care professionals from the Division of Drug Information. On September 13, 2019, FDA warned that […]
January 19, 2022

FDA warns about rare but serious risks of stroke and blood vessel wall tears with multiple sclerosis drug Lemtrada (alemtuzumab)

Listen Welcome to the FDA Drug Safety Podcast for health care professionals from the Division of Drug Information. This is Lesley Navin Advanced Practice Nurse. On […]
January 19, 2022

Fat Burners Zone Issues Voluntary Nationwide Recall of Zero Xtreme Due to Presence of Undeclared Sibutramine

Summary Company Announcement Date: October 15, 2018 FDA Publish Date: March 17, 2020 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to Presence of […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0